One of the S&P 500’s big losers for Monday January 04 was Varian Medical Systems Inc. (VAR). The company’s stock fell 3.22% to $78.20 on volume of 924,805 shares.
The stock opened the day at 79.73 and traded between a low of $78.15 and a high of $80.25. The stock finished the day down $2.6 per share. Varian Medical Systems Inc. has an average daily volume of 857,904 and a total float of 96.88 million shares. The 50-day SMA for Varian Medical Systems Inc. is $79.45 and its 200-day SMA is $84.18. The high for the stock over the last 52 weeks is $96.67 and the low is $71.07.
Varian Medical Systems Inc manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Varian Medical Systems Inc. is centered in Palo Alto, CA, and has 7,300 employees. Today’s trading day leaves the company with a market cap of $7.58 billionwith a P/E Ratio of 19.8. The company has a P/S ratio of 3.32, P/B ratio of 4.43, and a 34.7.
For a complete fundamental analysis analysis of Varian Medical Systems Inc., check out Equities.com’s Stock Valuation Analysis report for VAR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.
While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.